SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Acne Drug Linked To Depression, Centre Hospitalier Universitaire de Quebec Sainte-Justine Research Centre Study Shows
May 27, 2008
 · 
1 min read
Drug Development
Anti-Rejection Drug May Increase Risk Of Diabetes After Kidney Transplant, University of British Columbia Study Shows
May 27, 2008
 · 
1 min read
Drug Development
Antipsychotic Drugs, Including Eli Lilly and Company’s Zyprexa And Johnson & Johnson’s Risperdal, Triple Risk of Death for Dementia Patients
May 27, 2008
 · 
1 min read
Drug Development
DHEA Supplements Not Effective In Treating Cognitive Decline, Study In Journal of the American Geriatrics Society Suggests
May 27, 2008
 · 
1 min read
Drug Development
No Link Found Between Antidepressants And Birth Defects, According To New Study From Université de Montréal And Ste. Justine Hospital
May 23, 2008
 · 
1 min read
Drug Development
Common Foodborne Pathogen In Poultry Finds Resistance To Antibiotic Used By Humans, University of Arkansas Study
May 23, 2008
 · 
1 min read
Drug Development
Probiotics Weight Loss After Bypass Surgery, Stanford University Study
May 23, 2008
 · 
1 min read
Drug Development
New Treatments Extend Brain Cancer Survival A Bit, New York University And Brain Tumor Center Study
May 22, 2008
 · 
1 min read
Drug Development
Drug Therapy Doesn’t Buy Time In Heart Attack, Cleveland Clinic Study Finds
May 22, 2008
 · 
1 min read
Drug Development
Two Drugs For Heart Failure Show Mixed Results; Novartis Pharmaceuticals Corporation’s Diovan Should Be Used More Often And Scios Inc.'s Natrecor Should Not Be Used At All, VA Medical Center And Baylor University Research Shows
May 22, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Savient Pharmaceuticals, Inc. Release: New Data Published in Annals of the Rheumatic Diseases Confirm Long-Term Safety and Efficacy of KRYSTEXXA® for the Treatment of Refractory Chronic Gout
November 12, 2012
 · 
9 min read
Drug Development
Genentech Presents Positive Data for Actemra in Rheumatoid Arthritis
November 12, 2012
 · 
1 min read
Drug Development
Plexxikon Inc. Announces Three-Year Survival in Zelboraf-Treated Metastatic Melanoma Patients
November 9, 2012
 · 
1 min read
Drug Development
Okuvision GmbH Initiates Multi-Center, Post-Market Study
November 8, 2012
 · 
4 min read
Drug Development
Eli Lilly and Company Release: Cardiovascular Outcome Study on Tradjenta® (Linagliptin) Tablets in Adult Patients With Type 2 Diabetes Completes Enrollment
November 8, 2012
 · 
9 min read
Drug Development
Boehringer Ingelheim Corporation Release: RELY-ABLE®: Unprecedented Long-Term Data Support Safety Profile and Sustained Efficacy of Pradaxa® for Stroke Prevention in AF
November 8, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation Release: Recruitment Complete for Trajenta ® (linagliptin) Cardiovascular Outcome Study in Patients With Type 2 Diabetes
November 8, 2012
 · 
1 min read
Drug Development
AstraZeneca PLC Release: New PLATO Analysis Evaluates the Influence of High-Sensitivity Troponin Biomarker Status in NSTE-ACS Patients Managed With Revascularization or Medical Management
November 7, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation Release: Safety and Efficacy of Pradaxa® (dabigatran etexilate) Reconfirmed in Clinical Setting for VTE Prevention After Total Knee or Hip Replacement
November 6, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim GmbH Release: FDA and FDA Reaffirm Important Health Benefits and Safety of Pradaxa® (dabigatran etexilate) for Patients With Atrial Fibrillation
November 5, 2012
 · 
1 min read
Drug Development
Novartis AG Drug Works to Treat Rare Cushing’s Disease
November 5, 2012
 · 
1 min read
Drug Development
GlaxoSmithKline, Roche Drugs Help Treat Breast Cancer in Brain
November 2, 2012
 · 
1 min read
Drug Development
Data in The New England Journal of Medicine Show Novartis AG Drug Aclasta® Significantly Reduced the Risk of Fracture in Men With Osteoporosis With Once-Yearly Infusion
November 1, 2012
 · 
10 min read
Drug Development
Wealth of Worldwide Evidence on Boehringer Ingelheim GmbH’s Pradaxa® Including First Clinical Data on Long-Term Efficacy and Safety of a Novel Oral Anticoagulant to be Presented at American Heart Association Scientific Sessions
October 31, 2012
 · 
1 min read
Drug Development
ASTRO Release: Sildenafil Citrate Improves Overall Sexual Function of Prostate Cancer Patients Receiving Radiation Therapy
October 29, 2012
 · 
1 min read
Drug Development
Novartis AG Cannibalizes Gleevec to Boost New Cancer Drug
October 26, 2012
 · 
1 min read
Drug Development
Celgene International Sárl Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients
October 25, 2012
 · 
1 min read
Drug Development
Eli Lilly and Company Release: New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Presented at TCT
October 24, 2012
 · 
14 min read
Drug Development
Abbott Laboratories Announces Three-Year Long-Term Data Evaluating Efficacy with HUMIRA® (Adalimumab) for Patients With Moderately to Severely Active Ulcerative Colitis
October 23, 2012
 · 
8 min read
Drug Development
Zogenix, Inc. to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology
October 23, 2012
 · 
1 min read
Load More